Skip to main content
    N

    Nutriband Inc (NTRB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.81
    -0.29 (-4.75%)

    Market Cap: $74.15M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Nutriband Inc (NTRB) Financials: Revenue, Profit and Cash Flow

    Updated Sep 4, 2026. Financial statements from company filings, amounts in US dollars.

    Nutriband reported revenue of $2.04M for the fiscal year ended Jan 31, 2026, down 4.8% from the year before. That year, net income was -$8.23M with a net margin of -404.1%, operating cash flow was -$5.13M and free cash flow was -$5.14M. The quarter ended Jul 31, 2026 had revenue of $437.51K and net income of -$880.56K.

    Revenue and Margins

    Over the 7 years to Jan 2026, revenue grew from $245.28K, a compound annual rate of 35.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jan 2026$2.04M-4.8%27.8%-408.4%-404.1%
    Jan 2025$2.14M+2.6%34.7%-480.7%-489.9%
    Jan 2024$2.09M+0.3%41.3%-233.6%-263.0%
    Jan 2023$2.08M+46.2%36.1%-215.2%-215.6%
    Jan 2022$1.42M+50.7%35.5%-429.7%-434.3%
    Jan 2021$943.70K+154.6%33.5%-275.1%-310.8%
    Jan 2020$370.65K+51.1%-48.1%-531.4%-734.3%
    Jan 2019$245.28KN/A-17.5%-1358.1%-1358.1%
    Jan 2018$0N/AN/AN/AN/A
    Jan 2017$0N/AN/AN/AN/A
    Annual, fiscal years ended Jan 2017 to Jan 2026

    Income Statement

    In the fiscal year ended Jan 2026, the net loss narrowed from the year before. In the quarter ended Jul 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Revenue$2.04M$2.14M$2.09M$2.08M$1.42M$943.70K$370.65K$245.28K$0$0
    Cost of revenue$1.47M$1.40M$1.22M$1.33M$917.84K$627.38K$549.11K$288.30K$0$0
    Gross profit$566.31K$743.32K$862.11K$750.41K$504.31K$316.32K-$178.46K-$43.02K$0$0
    Research and development$1.89M$3.12M$1.96M$982.23K$411.38K$0$0$0$0$0
    Operating income-$8.32M-$10.28M-$4.87M-$4.48M-$6.11M-$2.60M-$1.97M-$3.33M-$2.67M-$151.26K
    Net income-$8.23M-$10.48M-$5.49M-$4.48M-$6.18M-$2.93M-$2.72M-$3.33M-$2.67M-$151.26K
    EBITDA-$8.12M-$10.00M-$4.58M-$4.15M-$5.69M-$2.21MN/A-$3.29M-$2.67M-$151.26K
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Revenue$437.51K$433.40K$400.71K$346.06K$622.45K$667.43K$642.38K$645.80K$442.83K$408.53K$524.61K$427.84K
    Gross profit$181.87K$196.80K$88.94K$68.50K$156.88K$251.98K$274.62K$191.03K$101.56K$164.79K$181.23K$158.92K
    Operating income-$890.64K-$1.25M-$1.02M-$3.88M-$2.00M-$1.41M-$1.96M-$1.43M-$1.41M-$1.89M-$1.31M-$1.72M
    Net income-$880.56K-$1.24M-$968.06K-$3.87M-$2.00M-$1.39M-$5.52M-$1.36M-$1.71M-$1.90M-$1.88M-$1.76M
    Last 12 quarters

    Balance Sheet

    As of Jan 2026, cash and equivalents exceeded total debt of $164.73K by $4.41M.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Total assets$7.55M$7.47M$7.52M$9.46M$12.74M$9.93M$2.20M$2.81M$164.90K$37.73K
    Current assets$4.99M$4.79M$1.02M$2.69M$5.47M$314.19K$43.18K$590.47K$164.90K$37.73K
    Cash and equivalents$4.57M$4.31M$492.94K$1.99M$4.89M$151.99K$10.18K$474.65K$0$27.12K
    Total liabilities$868.45K$1.04M$1.08M$883.39K$880.38K$2.82M$2.02M$403.01K$43.39K$14.62K
    Short-term debt$128.87K$128.14K$127.18K$19.74K$14.12K$1.52M$311.57K$40.00K$16.82K$1.58K
    Long-term debt$35.86K$58.20K$79.83K$100.50K$101.12K$150.06K$0$0$0$0
    Shareholder equity$6.68M$6.43M$6.44M$8.57M$11.86M$7.11M$175.43K$2.40M$121.51K$23.11K
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total assets$6.29M$6.89M$7.55M$8.42M$10.18M$6.15M$7.47M$12.54M$13.63M$15.15M$7.52M$8.52M
    Total liabilities$964.36K$902.31K$868.45K$870.21K$1.68M$1.05M$1.04M$1.31M$1.17M$1.79M$1.08M$2.81M
    Cash and equivalents$3.42M$4.01M$4.57M$5.31M$7.00M$2.96M$4.31M$5.70M$6.76M$8.35M$492.94K$1.27M
    Shareholder equity$5.33M$5.99M$6.68M$7.55M$8.49M$5.10M$6.43M$11.23M$12.46M$13.36M$6.44M$5.71M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Jan 2026.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Operating cash flow-$5.13M-$4.63M-$3.53M-$2.99M-$2.81M-$297.06K-$894.47K-$1.11M-$92.86K-$147.92K
    Capital expenditures$5.32K$92.04K$51.76K$79.30K$81.59K$0$81.59K$4.16K$4.16K$4.16K
    Free cash flow-$5.14M-$4.72M-$3.58M-$3.07M-$2.89M-$297.06K-$976.07K-$1.11M-$97.02K-$152.09K
    Dividends paidN/AN/AN/A$296.88K$196.59KN/AN/A$0$2.50M$0
    Share repurchases$0$148.55K$0$119.01K$104.47K$0N/AN/AN/AN/A
    Investing cash flow-$5.32K-$92.04K-$51.76K-$79.30K-$81.59K$66.99K$0-$404.16K$0$0
    Financing cash flow$5.40M$8.54M$2.09M$160.07K$7.63M$371.87K$430.25K$1.98M$65.76K$174.90K
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Operating cash flow-$585.00K-$563.10K-$731.83K-$1.75M-$1.31M-$1.34M-$1.24M-$1.01M-$1.63M-$833.93K-$718.24K-$431.60K
    Capital expendituresN/A$0$5.32K$3$5.32K$5.32K$4$46.96K$42.46K$6.20K$49.14K$42.46K
    Free cash flowN/A-$563.10K-$737.15K-$1.75M-$1.32M-$1.34M-$1.24M-$1.06M-$1.67M-$840.12K-$767.38K-$474.06K
    Last 12 quarters

    Frequently Asked Questions About NTRB

    What is Nutriband's annual revenue?

    Nutriband reported revenue of $2.04M for the fiscal year ended Jan 31, 2026.

    How fast is Nutriband's revenue growing?

    Revenue was down 4.8% for the fiscal year ended Jan 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -0.7%.

    Is Nutriband profitable?

    No. Nutriband reported net income of -$8.23M for the fiscal year ended Jan 31, 2026, with a net margin of -404.1%.

    How much free cash flow does NTRB generate?

    For the fiscal year ended Jan 31, 2026, operating cash flow of -$5.13M minus capital expenditures of $5.32K produced free cash flow of -$5.14M.

    How much debt does Nutriband have?

    The balance sheet dated Jan 31, 2026 reported long-term debt of $35.86K, short-term debt of $128.87K and cash and equivalents of $4.57M.